Research report

North America Insulin Pump Market Prospect, Share, Development, Growth and Demand Forecast to 2022

Format : Pdf

Publish Date: 25th July 2017

Pages: 190

North America Insulin Pump Market is likely to reach more than US$ 4.2 Billion by the year end of 2022.

Increasing number of diabetic patients, growing awareness towards diabetes, improved glucose control and flexible, lifestyle–compatible treatment options and technological advancement in insulin pump devices are the key factors driving the growth of the North America Insulin Pump Market. However, high cost of the insulin pump devices is expected to hamper growth of the market during forecast period.
North America Insulin Pump Market is likely to reach more than US$ 4.2 Billion by the year end of 2022.

Long–term Growth Projection:

Number of diabetes population in United States will increase to more than 33 Million
   by the year end of 2022
    
In 2016, there were more than 5,00,000 insulin pump users in United States

Canada Insulin Pump market generated more than US$ 160 Million in 2016

The US is the major market share holder for the North America Insulin Pump Market

Increasing number of diabetic patients, growing awareness towards diabetes, improved glucose control and flexible, lifestyle–compatible treatment options and technological advancement in insulin pump devices are the key factors driving the growth of the North America Insulin Pump Market. However, high cost of the insulin pump devices is expected to hamper growth of the market during forecast period.

“North America Insulin Pump Market Prospect, Share, Development, Growth and Demand Forecast to 2022” provides a deep and thorough evaluation of the North America Insulin Pump Market. The report provides an in–depth analysis of the type 1, type 2, newly diagnosed type 1 diabetes and overall diabetes population of all the three countries covered in the report. It provides an essential insights of insulin pump users in terms of volume in detail for latest trends, outlook and opportunities in all the three countries covered in the report.

Market outlook in value terms has been analyzed based on current and potential trends and the market is estimated from 2017 to 2022. Additionally, the report includes assessment of clinical trials and preferred insulin pump brand by the patients. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Key trends in terms of collaborations, partnerships and licensing agreements are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the North America Insulin Pump Market.

The report concludes with the profiles of major players in the Insulin Pump Market such as Insulet Corporation, Medtronic, Roche, Animas Corporation, Tandem Diabetes Care, Microport and Sooil Development. The major market players are evaluated on various parameters such as company overview, product outlook, latest development and trends and sales analysis of the Insulin Pump and Diabetes Market from 2011 to 2022. 

Key Topics Covered in the Report

United States, Canada & Mexico Diabetes Population Analysis (2011 – 2022)
North America Insulin Pump Users & Market Prospect & Growth (2011 – 2022)
North America Insulin Pump Users & Market Share – By Countries (2011 – 2022)
North America Insulin Pump Market Analysis – By Countries (2011–  2022)
United States Insulin Pump Users and Market Analysis (2011 – 2022)
United States Insulin Pump Preferred Brand – By Product
Canada Insulin Pump Users and Market Analysis (2011 – 2022)
Mexico Insulin Pump Users and Market Analysis (2011 – 2022)
North America (All 3 Countries) Insulin Pump Reimbursement & Regulation System
North America Insulin Pump Market – Major Deal Types
Insulin Pump Market Clinical Trail Insight by Phase, Company & Country
Key Drivers and Inhibitors of the North America Insulin Pump Market
Key Companies Analysis

Major Countries Covered in This Report:

United States
Canada
Mexico

Major Companies Covered in This Report:

Insulet Corporation
Medtronic
Roche 
Animas Corporation
Tandem Diabetes Care
Microport
Sooil Development

1. Executive Summary

2. North America Diabetes Population (2011 – 2022): An Analysis
 
2.1 United States
2.1.1 Overall Diabetes Population
2.1.1.1 Type 1 Diabetes
2.1.1.2 Type 2 Diabetes
2.1.1.3 Newly Diagnosed Type 1 Diabetes
 
2.2 Canada
2.2.1 Overall Diabetes Population
2.2.1.1 Type 1 Diabetes
2.2.1.2 Type 2 Diabetes
2.2.1.3 Newly Diagnosed Type 1 Diabetes
 
2.3 Mexico
2.3.1 Overall Diabetes Population
2.3.1.1 Type 1 Diabetes
2.3.1.2 Type 2 Diabetes
2.3.1.3 Newly Diagnosed Type 1 Diabetes
 
3. North America Insulin Pump Market Prospect & Growth (2011 – 2022) 
 
3.1 Insulin Pump Users
3.2 Insulin Pump Market
 
4. North America Insulin Pump Market Share – By Countries (2011 – 2022) 
 
4.1 Insulin Pump Users Share
4.2 Insulin Pump Market Share
 
5. North America Insulin Pump Market Analysis – By Countries (2011–  2022) 
 
5.1 United States
5.1.1 Insulin Pump Users
5.1.2 Insulin Pump Market
5.1.3 United States Insulin Pump Preferred Brand – By Product
5.1.3.1 Pediatric
5.1.3.2 Adult
 
5.2 Canada
5.2.1 Insulin Pump Users
5.2.2 Insulin Pump Market
 
5.3 Mexico
5.3.1 Insulin Pump Users
5.3.2 Insulin Pump Market
 
6. Key Drivers and Inhibitors of the North America Insulin Pump Market
 
6.1 Market Drivers
6.2 Inhibitors
 
7. North America Insulin Pump Market: Reimbursement & Regulation System
 
7.1 United States
7.1.1 Reimbursement System
7.1.2 Regulation System
 
7.2 Canada
7.2.1 Reimbursement System
7.2.2 Regulation System
 
7.3 Mexico
7.3.1 Regulation System
 
8. North America Insulin Pump Market – Major Deal Types
 
8.1 Insulin Pump Market – Collaboration Deals
8.2 Insulin Pump Market – Licensing Agreement
8.3 Insulin Pump Market – Exclusive Agreement
8.4 Insulin Pump Market – Partnerships Deals
 
9. Insulin Pump Market Clinical Trail Insight by Phase, Company & Country
 
9.1 Year 2016
9.2 Year 2015
9.3 Year 2014
9.4 Year 2013
9.5 Year 2012
 
10. Key Companies Analysis
 
10.1 Medtronic
10.1.1 Business Overview
10.1.2 Insulin Pump – Product Details
10.1.3 Medtronic – United States Diabetes Sales Analysis & Forecast (2013 – 2022) 
10.1.4 Insulin Pump – Latest Development & Trends
 
10.2 Tandem Diabetes Care
10.2.1 Business Overview
10.2.2 Insulin Pump – Product Details
10.2.3 Tandem Diabetes Care – Insulin Pump Sales Analysis & Forecast (2013 – 2022) 
10.2.4 Insulin Pump – Latest Development & Trends
 
10.3 Insulet Corporation
10.3.1 Business Overview
10.3.2 Insulin Pump – Product Details
10.3.3 Insulet Corporation – Insulin Pump Sales Analysis & Forecast (2011 – 2022) 
10.3.4 Insulin Pump – Latest Development & Trends
 
10.4 Animas Corporation (Johnson & Johnson) 
10.4.1 Business Overview
10.4.2 Insulin Pump – Product Details
10.4.3 Johnson & Johnson – United States Diabetes Sales Analysis & Forecast (2013 – 2022) 
10.4.4 Insulin Pump – Latest Development & Trends
 
10.5 Roche
10.5.1 Business Overview
10.5.2 Insulin Pump – Product Details
10.5.3 Roche – North America Diabetes Sales Analysis & Forecast (2011 – 2022) 
10.5.4 Insulin Pump – Latest Development & Trends
 
10.6 Microport
10.6.1 Business Overview
10.6.2 Insulin Pump –  Product Details
10.6.3 Microport – Global Diabetes Sales Analysis & Forecast (2013 – 2022) 
10.6.4 Insulin Pump – Latest Development & Trends
 
10.7 Sooil Development
10.7.1 Business Overview
10.7.2 Insulin Pump – Product Details
10.7.3 Insulin Pump – Latest Development & Trends

List of Tables :

Table 4–1: North America – Insulin Pump Users Share (Percent), 2011 – 2016
Table 4–2: North America – Forecast for Insulin Pump Users Share (Percent), 2017 – 2022
Table 4–3: North America – Insulin Pump Market Share (Percent), 2011 – 2016
Table 4–4: North America – Forecast for Insulin Pump Market Share (Percent), 2017 – 2022
Table 6–1: Worldwide – Healthcare Spending on Diabetes (Billion US$), 2015 & 2040
Table 8–1: Collaboration Deals in Insulin Pump Market, 2009 – 2016
Table 8–2: Licensing Agreement in Insulin Pump Market, 2015 – 2016
Table 8–3: Exclusive Agreement in Insulin Pump Market, 2011 – 2017
Table 8–4: Partnerships Deals in Insulin Pump Market, 2010 – 2017

List of Figures :

Figure 2–1: United States – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 2–2: United States – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 2–3: United States – Type 1 Diabetes Population (Thousand), 2011 – 2016
Figure 2–4: United States – Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2022
Figure 2–5: United States – Type 2 Diabetes Population (Thousand), 2011 – 2016
Figure 2–6: United States – Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2022
Figure 2–7: United States – Newly Diagnosed Type 1 Diabetes Population (Number), 2011 – 2016
Figure 2–8: United States – Forecast for Newly Diagnosed Type 1 Diabetes Population (Number), 2017 – 2022
Figure 2–9: Canada – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 2–10: Canada – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 2–11: Canada – Type 1 Diabetes Population (Thousand), 2011 – 2016
Figure 2–12: Canada – Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2022
Figure 2–13: Canada – Type 2 Diabetes Population (Thousand), 2011 – 2016
Figure 2–14: Canada – Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2022
Figure 2–15: Canada – Newly Diagnosed Type 1 Diabetes Population (Number), 2011 – 2016
Figure 2–16: Canada – Forecast for Newly Diagnosed Type 1 Diabetes Population (Number), 2017 – 2022
Figure 2–17: Mexico – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 2–18: Mexico – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 2–19: Mexico – Type 1 Diabetes Population (Thousand), 2011 – 2016
Figure 2–20: Mexico – Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2022
Figure 2–21: Mexico – Type 2 Diabetes Population (Thousand), 2011 – 2016
Figure 2–22: Mexico – Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2022
Figure 2–23: Mexico – Newly Diagnosed Type 1 Diabetes Population (Number), 2011 – 2016
Figure 2–24: Mexico – Forecast for Newly Diagnosed Type 1 Diabetes Population (Number), 2017 – 2022
Figure 3–1: North America – Insulin Pump Users (Number), 2011 – 2016
Figure 3–2: North America – Forecast for Insulin Pump Users (Number), 2017 – 2022
Figure 3–3: North America – Insulin Pump Market (Million US$), 2011 – 2016
Figure 3–4: North America – Forecast for Insulin Pump Market (Million US$), 2017 – 2022
Figure 5–1: United States – Insulin Pump Users (Number), 2011 – 2016
Figure 5–2: United States – Forecast for Insulin Pump Users (Number), 2017 – 2022
Figure 5–3: United States – Insulin Pump Market (Million US$), 2011 – 2016
Figure 5–4: United States – Forecast for Insulin Pump Market (Million US$), 2017 – 2022
Figure 5–5: United States –  Pediatric Insulin Pump Preference by Product(Percent),2016
Figure 5–6: United States –  Adult Insulin Pump Preference by Product(Percent),2016
Figure 5–7: Canada – Insulin Pump Users (Number), 2011 – 2016
Figure 5–8: Canada – Forecast for Insulin Pump Users (Number), 2017 – 2022
Figure 5–9: Canada – Insulin Pump Market (Million US$), 2011 – 2016
Figure 5–10: Canada – Forecast for Insulin Pump Market (Million US$), 2017 – 2022
Figure 5–11: Mexico – Insulin Pump Users (Number), 2011 – 2016
Figure 5–12: Mexico – Forecast for Insulin Pump Users (Number), 2017 – 2022
Figure 5–13: Mexico – Insulin Pump Market (Million US$), 2011 – 2016
Figure 5–14: Mexico – Forecast for Insulin Pump Market (Million US$), 2017 – 2022
Figure 10–1: Medtronic – United States Diabetes Sales Analysis (Million US$),2013 – 2016
Figure 10–2: Medtronic – Forecast for United States Diabetes Sales Analysis (Million US$),2017 – 2022
Figure 10–3: Tandem Diabetes Care – Insulin Pump Sales Analysis (Million US$),2013 – 2016
Figure 10–4: Tandem Diabetes Care – Forecast for Insulin Pump Sales Analysis (Million US$),2017 – 2022
Figure 10–5: Insulet Corporation – Insulin Pump Sales Analysis (Million US$),2011 – 2016
Figure 10–6: Insulet Corporation – Forecast for Insulin Pump Sales Analysis (Million US$),2017 – 2022
Figure 10–7: Johnson & Johnson – United States Diabetes Sales Analysis (Million US$),2013 – 2016
Figure 10–8: Johnson & Johnson – United States Diabetes Sales Analysis (Million US$),2017 – 2022
Figure 10–9: Roche – North America Diabetes Sales Analysis (Million US$),2011 – 2016
Figure 10–10: Roche – Forecast for North America Diabetes Sales Analysis (Million US$),2017 – 2022
Figure 10–11: Microport – Diabetes Sales Analysis (Million US$),2013 – 2016
Figure 10–12: Microport – Forecast for Diabetes Sales Analysis (Million US$),2017 – 2022

 

United States Insulin Pump Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2022